Lecture Series: Treating “Untreatable” Cancer with Uniquely Personalized Gene Therapy

Animated rendering of DNA “double helix”

Learn how modern medical technology is learning to treat “untreatable” cancer with personalized gene therapy at the next Medical Center Lecture Series presentation at 5 p.m. Tuesday, March 12.

This informative lecture, sponsored by the Medical Lecture Series and Healthnetwork Foundation, will be presented by Dr. Bruce Levine, Director of the University of Pennsylvania Abramson Cancer Center’s Clinical Cell and Vaccine Production Facility (CVPF) in Philadelphia. Through clinical patient trials, the CVPF develops and tests novel cell and gene therapies for genetic diseases, hematologic malignancies, tumors and infectious diseases. Using this technology, the facility can engineer personalized and enhanced immunity.

Dr. Levine, who founded the CVPF, has been issued 23 patents and co-authored more than 130 publications. He has been interviewed by the New York Times, Wall Street Journal, National Geographic, Forbes Magazine, the BBC and other international media outlets.

Cancer has touched everyone’s lives, and the CVPF is engineering new ways to treat it. We hope you will join us in the Cultural Center Theatre to learn about Dr. Levine and the advances his facility is making into cancer treatment. As with all lectures in the 2019 series, cocktails and light hors d’oeuvres will follow the lecture, when you will have the opportunity to meet Dr. Levine. For more information about this lecture and the remaining lectures in the 2019 Medical Center Lecture Series, click here.

Cancer Statistics at a Glance

  • The number of new cancer cases is expected to rise to 23.6 million per year by 2030.
  • Estimated national expenditures for cancer care in the United States were $147.3 billion in 2017. Costs are likely to increase as the population ages and more expensive treatments are adopted.
  • In 2018, an estimated 1,735,350 new cases of cancer were diagnosed in the United States alone.
  • The most common cancers in 2018 (listed in descending order) are breast, lung and bronchus, prostate, colon, rectal, skin melanoma, bladder, non-Hodgkins lymphoma, kidney and renal pelvis cancers, endometrial, leukemia, pancreatic, thyroid and liver.Source: National Cancer Institute

Support the Medical Center by shopping with AmazonSmile. It’s the same Amazon you know, but Amazon donates 0.5% of the price of your eligible AmazonSmile purchases to the Medical Center. Your prices stay the same. Click here to learn more.